About Protagonist (PTGX)
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant unmet medical needs. The Company's product pipel... Read more
- USD26.20
- USD26.59
- USD25.75
- USD33.34
- -7.10%
- 60M
- 522.48k
- 1.5B
- 13.72
- 6.70%
- 66.90%
Stock News
4 hours ago
Three Leading Canadian Dividend Stocks With Yields Up To 5.5%
Yahoo
4 hours ago
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Yahoo
5 hours ago
Deckers Outdoor Corporation (DECK) Continued its Strong Performance in Q1
Yahoo
5 hours ago
Cable One (CABO) Impacted by Challenging Market Environment
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
